Back to search

Article

High-coverage immunopeptidomics using timsTOF mass spectrometers with Thunder-DDA-PASEF boosted by MS2Rescore

2024-08-06

Abstract excerpt

<title>Abstract</title> <p> Major histocompatibility complex (MHC, or Human leukocyte antigen, HLA) peptide ligands can be exploited to develop immunotherapies targeting immunogenic disease-specific immunopeptides, such as virus- or cancer mutation-derived peptides. Liquid chromatography-coupled with mass spectrometry (LC-MS)-based immunopeptidomics is the gold standard for identifying MHC ligands. We previously...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bc633b99-3e45-5657-8f22-a0b026502c90
DOI
10.21203/rs.3.rs-4849156/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
High-coverage immunopeptidomics using timsTOF mass spectrometers with Thunder-DDA-PASEF boosted by MS2RescoreDOI 10.21203/rs.3.rs-4849156/v1
Select a neighboring publication to make it the new centre.